Best Inulin in Canada (2026)
November 1, 2026Best Pycnogenol in Canada (2026)
November 2, 2026Quick Summary
A small German trial gave 67 women with thinning bones either a standardized pine bark extract or a placebo for three months. The extract group reported less bodily pain and more energy than the placebo group. But the bone-breakdown markers did not beat placebo head-to-head, so this is about feeling better, not proof of stronger bones. The research was partly funded by the extract’s maker.
Here is the twist worth pausing on: after three months, the extract group’s pain scores had climbed while the placebo group’s had slipped, and the gap held up after adjusting for where everyone started. Yet the lab tests meant to show slower bone breakdown told a much muddier story.
| Topic | What the research shows |
|---|---|
| Who was studied | 67 women with osteopenia or stable osteoporosis, one centre in Würzburg, Germany |
| What they took | 200 mg per day of Pycnogenol, standardized French maritime pine bark extract, as 100 mg twice daily |
| How long | 3 months against placebo, then 3 more months in which everyone got the extract |
| Clearest result | Pain and vitality scores better with the extract than with placebo at 3 months |
| The catch | Bone markers fell in the extract group but did not beat placebo at any visit |
| Funding note | Supported by an educational grant from Horphag Research, the extract’s maker |
What the trial actually tested
Bones are constantly broken down and rebuilt. When breakdown outpaces rebuilding, density falls — the slow slide from osteopenia, where density is below normal, toward osteoporosis. Researchers in Würzburg asked whether a pine bark extract rich in plant compounds called procyanidins could nudge that balance.
All 67 participants were women with low bone density who were not taking bone-specific prescription drugs. They were randomly assigned to the extract or identical placebo capsules, and neither the women nor their treating doctors knew who got what for the first three months. After that, the placebo group switched to the extract too, so the second half compared longer versus shorter exposure, not extract versus placebo.
The results that matter — and the one that does not quite land
Start with how the women felt, because that is where the trial is strongest. On the SF-36 bodily pain scale (higher means less pain), the extract group rose from 57.46 to 68.07 after three months, while the placebo group slipped from 55.35 to 51.93. At three months the extract group scored 68.07 against 51.93 for placebo, and the gap survived adjustment for baseline scores (13.77 points, p = 0.0106). Vitality was similar but softer: 64.62 versus 54.36, a baseline-adjusted gap of 8.47 points (p = 0.0282), although the vitality rise within the extract group alone did not reach significance.
Now the bloodwork, where honesty matters more than hype. In the extract group, the bone-breakdown marker CTX-1 fell from 417.8 pg/mL to 373.7 pg/mL at three months, significant within that group (p = 0.0327). A second breakdown marker, NTX-1, also fell significantly within the extract group by six months. But the placebo group’s CTX-1 fell too, from 421.7 to 379.5 pg/mL, and the researchers found no significant difference between groups at any visit. The bone-formation marker P1NP did not change significantly in either group.
| Measure at 3 months | Extract group | Placebo group |
|---|---|---|
| SF-36 bodily pain score | 68.07 (up from 57.46) | 51.93 (down from 55.35) |
| SF-36 vitality score | 64.62 (up from 56.07) | 54.36 (from 53.71) |
| CTX-1, bone-breakdown marker | 373.7 pg/mL (from 417.8) | 379.5 pg/mL (from 421.7) |
| P1NP, bone-formation marker | No significant change | No significant change |
Put plainly: the women on the extract reported less pain and a bit more energy than those on placebo, but the lab tests do not prove the extract slowed bone breakdown better than a dummy pill. The trial measured no fractures and reported no bone-density result, so nothing here shows fewer broken bones. A gut-microbe metabolite of the extract, called M1, was higher in the extract group’s saliva at three months and weakly linked to lower CTX-1 — an interesting clue, not a conclusion.
Why researchers are still cautious
Three caveats deserve as much attention as the headline numbers. First, this was small and single-centre: 67 women, with only the first three months truly placebo-controlled. Second, some questionnaire data went missing, and the disease-specific quality-of-life questionnaire showed no significant difference between groups. Third, the study was supported by an educational grant from Horphag Research, the company behind the extract, to two authors. The authors declared no conflict of interest, but industry funding is a reason to want independent replication, not to dismiss the trial outright.
Safety data were reassuring as far as they go: blood counts and liver and kidney markers stayed in their normal ranges over six months, phosphate dipped slightly while staying in range, and only one participant on the extract stopped because of a possibly related event — dizziness, rated mild.
What is pycnogenol and how is it supposed to work?
Pycnogenol is a standardized extract from the bark of the French maritime pine, Pinus pinaster, grown in southwestern France. “Standardized” is the key word: it is held to 65–75% oligomeric procyanidins, a family of plant polyphenols, plus smaller amounts of phenolic acids such as catechin, ferulic acid and caffeic acid. That consistency is why researchers can study it at all — plain pine bark powder is not the same thing.
The proposed mechanism is familiar from other polyphenol research: procyanidins act as antioxidants and may help calm inflammation, and inflammation is part of the environment in which bone breakdown speeds up. In lab dishes, extract components encouraged bone-forming stem cells to develop in a bone-building direction, and earlier animal studies suggested it might slow bone loss. This trial is the first to test the bone-turnover question in people with low bone density — and the human blood-marker evidence is still only suggestive. A 2024 review found the extract studied far more for circulation and joint comfort, usually at 60 to 300 mg per day, than for bone health.
What are the side effects of pycnogenol?
In this trial, the safety picture was quiet: lab markers stayed in range, and the only possibly related reason anyone on the extract stopped was one mild case of dizziness. That is reassuring, but it is also a narrow window — 67 women, six months, one centre.
A few groups should talk to a clinician first. Pine bark extracts have been linked in other trials to reduced platelet aggregation and lower blood-sugar measures, so people taking blood thinners, diabetes medicines or blood-pressure medicines should check for added effects before combining them. The same caution applies before surgery, and during pregnancy or breastfeeding, where safety is not established by this trial. Do not swap a prescribed bone medicine for a supplement without medical advice.
How much pycnogenol should you take?
There is no single established dose, so treat any confident number with suspicion. This trial used 200 mg per day, split into 100 mg twice daily, for three to six months. Other randomized trials used a wide range: 60 mg per day for menopausal symptoms, 100 to 150 mg per day for knee discomfort, and up to 300 mg per day for leg swelling. More is not better here — a higher dose has not been shown to protect bones more, and the bone-marker result was not a clear win even at 200 mg per day. Follow the product label and a clinician’s advice, and remember that calcium, vitamin D, weight-bearing exercise and fall prevention remain the foundations of bone care that no extract replaces.
What should you look for on the label?
The label should name French maritime pine bark extract (Pinus pinaster) standardized to 65–75% procyanidins — not just “pine bark” with no standardization, and not a proprietary blend that hides the amount. A blend total does not let you check whether you are getting anything close to a studied dose. In Canada, look for an eight-digit Natural Product Number (NPN): Health Canada says that number identifies a product licensed for sale in Canada, and you can check it in Health Canada’s Licensed Natural Health Products Database. Also look for third-party testing, a clear dose per capsule, and a servings count. Be wary of any bottle promising stronger bones or fracture prevention: this trial proved neither, and a label claiming them is selling past the evidence.
References
- Scherg, C., et al. (2026). Impact of a dietary intervention with French maritime pine bark extract (Pycnogenol®) on bone turnover markers in women with osteoporotic bone loss: A randomized, placebo-controlled double-blind study—Part I. Frontiers in Nutrition, 13, 1923949. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1923949/full
- Scherg, C., et al. (2026). Quality of life and safety of a dietary intervention with French maritime pine bark extract (Pycnogenol®) in women with osteoporotic bone loss: A randomized, placebo-controlled double-blind study—Part II. Frontiers in Nutrition, 13, 1924081. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1924081/full
- Weichmann, F., & Rohdewald, P. (2024). Pycnogenol® French maritime pine bark extract in randomized, double-blind, placebo-controlled human clinical studies. Frontiers in Nutrition, 11, 1389374. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2024.1389374/full
- Health Canada. (2018). Information sheet #5 for consumers: Informing yourself — Informing you about natural health products. http://www.hc-sc.gc.ca/dhp-mps/prodnatur/fiche_info_sheets_5-eng.php
This article reports on recent health research and is for general information only — it isn’t medical advice and doesn’t replace your doctor, pharmacist, or another qualified professional. Study findings describe what researchers observed, not a promise of results, and nothing here claims any supplement can diagnose, treat, cure, or prevent a disease. These statements have not been evaluated by Health Canada. Check with a healthcare professional before starting any new supplement, especially if you’re pregnant, nursing, taking medication, or managing a health condition.
